Last Updated: May 10, 2026

List of Excipients in Branded Drug 365 WHOLE FOODS MARKET GUAIFENESIN


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing 365 WHOLE FOODS MARKET GUAIFENESIN

Excipient Strategy and Commercial Opportunities for 365 Whole Foods Market Guaifenesin

Last updated: March 10, 2026

What is the Excipient Profile of 365 Whole Foods Market Guaifenesin?

The product is a store-brand formulation of guaifenesin, an expectorant used to relieve chest congestion. As a commercial OTC medication, the excipient profile influences stability, bioavailability, tolerability, and customer acceptance.

Typical Excipients in Guaifenesin Formulations

  • Microcrystalline cellulose: Filler and binder.
  • Starch (corn or potato): Disintegrant.
  • Magnesium stearate: Lubricant.
  • Silicon dioxide: Anti-caking agent.
  • Flavoring agents: For palatability.
  • Sweeteners: Often sorbitol or sucralose.

The specific excipients in 365 Whole Foods Market Guaifenesin are typically selected to support stability, tolerability, and consumer preference, aligning with organic or natural product positioning where applicable. These ingredients are generally recognized as safe (GRAS) and comply with FDA regulations for OTC drugs.

Formulation Strategy: Focus on Clean Label and Natural Ingredients

Given Whole Foods' emphasis on organic and natural products, excipient selection likely prioritizes:

  • Non-GMO ingredients.
  • Minimal artificial additives.
  • Avoidance of preservatives that conflict with natural branding.

This approach affects formulation choices, potentially increasing reliance on natural fillers or binders, which may influence manufacturing costs and shelf stability.

Commercial Opportunities in Excipient Development

Niche Positioning with Natural and Organic Excipients

  • Market Differentiation: Promoting the use of organic, non-GMO excipients appeals to health-conscious consumers.
  • Premium Pricing: Natural excipient formulations are often priced higher due to sourcing costs and regulatory compliance.
  • Brand Loyalty: Alignment with Whole Foods' brand identity can foster loyalty among consumers seeking transparency and clean-label products.

Regulatory and Supply Chain Considerations

  • Regulatory Compliance: Excipients must meet FDA OTC monograph standards and be classified as safe.
  • Supply Chain Risks: Sourcing organic excipients can encounter seasonal variability and higher costs.
  • Certification: Certification processes (e.g., USDA Organic) may lengthen time to market but can strengthen market positioning.

Innovation and Product Development Opportunities

  • Extended-Release Formulations: Incorporating natural excipients that support controlled release can differentiate products.
  • Combination Products: Using natural excipients enables the development of multi-active formulations aligned with consumer preferences.
  • Delivery Formats: Exploring alternative delivery systems (liquids, gummies) with natural excipients.

Market Dynamics and Consumer Trends

Growing Demand for Natural OTC Medications

  • Retail sales of natural OTC medications grew approximately 8% annually over the past five years, hitting $3.2 billion in 2022 (SPINS, 2022).
  • Consumers increasingly prefer products with transparent ingredient lists, favoring natural excipients over synthetic ones.

Competitive Landscape

  • Market players such as Nature's Way and Gaia Herbs focus on herbal and natural expectorants, but few utilize exclusively natural excipients in guaifenesin formulations.
  • Whole Foods Market's private label has an opportunity to capture a segment of the premium, clean-label OTC expectorant market.

Distribution Channels

  • Grocery stores and natural product outlets.
  • Online retail platforms targeting health-conscious consumers.
  • Pharmacies expanding natural or organic OTC sections.

Strategic Recommendations

  • Invest in sourcing and certifying natural, organic excipients.
  • Develop formulations emphasizing natural disintegrants and binders compatible with OTC standards.
  • Highlight natural and clean-label attributes in marketing to leverage consumer preferences.
  • Consider collaboration with suppliers offering verified organic excipients to ensure supply stability.
  • Explore patent protection for specific natural excipient combinations to create barriers for competitors.

Key Takeaways

  • Excipient selection for 365 Whole Foods Market Guaifenesin emphasizes natural, non-GMO ingredients to align with brand values.
  • Natural excipient formulations can support premium pricing, differentiation, and consumer trust.
  • Regulatory compliance and supply chain management pose challenges but can be mitigated with strategic sourcing.
  • There is a significant growth trend for natural OTC medications, representing a substantial market opportunity.
  • Innovation in delivery formats and controlled-release formulations using natural excipients expands product lines and market reach.

FAQs

1. How can natural excipients impact drug stability?
Natural excipients may have different moisture absorption and disintegration properties, potentially affecting shelf life and bioavailability. Formulation testing is essential.

2. Are natural excipients more expensive than synthetic ones?
Typically, yes. Sourcing organic and non-GMO excipients involves higher costs, but premium pricing can offset this.

3. What regulatory hurdles exist for natural excipients?
Excipients must meet FDA OTC monograph standards and be classified as GRAS. Certification for organic approval adds to the regulatory requirements.

4. Can natural excipients be used in all dosage formats?
Most, but some formats (e.g., sustained-release tablets) may require specialized excipients that might be synthetic. Alternative natural options exist but need validation.

5. How does consumer perception influence excipient choice?
A preference for transparent, clean-label ingredients increases demand for natural excipients, influencing formulation strategies.


References

[1] SPINS. (2022). Natural and Organic Product Trends.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.